The association between TNF-α inhibitors and psoriasiform eruptions was first suggested in a study of a cohort of 107 patients with spondyloarthropathy that were treated with infliximab, in which three patients without a personal or family history of psoriasis developed palmoplantar pustulosis [41]. The gene discussed is TNF; the disease is psoriasis.